AIMS AND METHODS: Delivery of high radiation doses while simultaneously sparing organs at risk requires advanced imaging for target volume definition, highly conformal dose distributions of intensity modulated radiotherapy (IMRT), and narrow planning target volume (PTV) margins. Three-dimensional image-guided radiotherapy (IGRT) with cone-beam computer tomography (CBCT), which results in more precise target localization, is quickly replacing two-dimensional (2D) IGRT. An overview on the clinical applications of kilovoltage gantry-mounted CBCT systems with emphasis on the most frequently targeted body sites (prostate, lung, head and neck) is provided based on a review of the relevant literature. Alternative imaging methods and their advantages/disadvantages are discussed. RESULTS: IGRT with soft tissue detection improves set-up accuracy and is currently replacing 2D verification and frame-based stereotactic treatments; safety margins are significantly reduced by this IGRT technology. In addition, systematic changes of tumor volume and shape and of the normal tissue can be monitored allowing for adaptation of radiotherapy. IGRT in combination with conformal treatment planning allows for hypofractionated dose escalation, which results in improved rates of local tumor control with low rates of toxicity. CONCLUSION: CBCT allows for daily pretreatment position verification and online correction of set-up errors which improves the precision of patient repositioning with the possibility of shrinking safety margins, sparing organs at risk, and escalating radiation doses. A trend for better clinical outcome can be observed.
AIMS AND METHODS: Delivery of high radiation doses while simultaneously sparing organs at risk requires advanced imaging for target volume definition, highly conformal dose distributions of intensity modulated radiotherapy (IMRT), and narrow planning target volume (PTV) margins. Three-dimensional image-guided radiotherapy (IGRT) with cone-beam computer tomography (CBCT), which results in more precise target localization, is quickly replacing two-dimensional (2D) IGRT. An overview on the clinical applications of kilovoltage gantry-mounted CBCT systems with emphasis on the most frequently targeted body sites (prostate, lung, head and neck) is provided based on a review of the relevant literature. Alternative imaging methods and their advantages/disadvantages are discussed. RESULTS: IGRT with soft tissue detection improves set-up accuracy and is currently replacing 2D verification and frame-based stereotactic treatments; safety margins are significantly reduced by this IGRT technology. In addition, systematic changes of tumor volume and shape and of the normal tissue can be monitored allowing for adaptation of radiotherapy. IGRT in combination with conformal treatment planning allows for hypofractionated dose escalation, which results in improved rates of local tumor control with low rates of toxicity. CONCLUSION: CBCT allows for daily pretreatment position verification and online correction of set-up errors which improves the precision of patient repositioning with the possibility of shrinking safety margins, sparing organs at risk, and escalating radiation doses. A trend for better clinical outcome can be observed.
Authors: Manuel Blessing; Dzmitry Stsepankou; Hansjoerg Wertz; Anna Arns; Frank Lohr; Jürgen Hesser; Frederik Wenz Journal: Int J Radiat Oncol Biol Phys Date: 2010-05-28 Impact factor: 7.038
Authors: Daniel Létourneau; Alvaro A Martinez; David Lockman; Di Yan; Carlos Vargas; Giovanni Ivaldi; John Wong Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-15 Impact factor: 7.038
Authors: Heng Li; X Ronald Zhu; Lifei Zhang; Lei Dong; Sam Tung; Anesa Ahamad; K S Clifford Chao; William H Morrison; David I Rosenthal; David L Schwartz; Radhe Mohan; Adam S Garden Journal: Int J Radiat Oncol Biol Phys Date: 2008-04-18 Impact factor: 7.038
Authors: M L Sautter-Bihl; F Sedlmayer; W Budach; J Dunst; P Feyer; R Fietkau; W Haase; W Harms; C Rödel; R Souchon; F Wenz; R Sauer Journal: Strahlenther Onkol Date: 2012-06 Impact factor: 3.621
Authors: G Z Gong; Y Yin; L G Xing; Y J Guo; T Liu; J Chen; J Lu; C Ma; T Sun; T Bai; G Zhang; R Wang Journal: Strahlenther Onkol Date: 2012-02-08 Impact factor: 3.621
Authors: Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald Journal: Transl Lung Cancer Res Date: 2017-12
Authors: Markus Oechsner; Barbara Chizzali; Michal Devecka; Stefan Münch; Stephanie Elisabeth Combs; Jan Jakob Wilkens; Marciana Nona Duma Journal: Strahlenther Onkol Date: 2017-07-19 Impact factor: 3.621
Authors: A De Puysseleyr; T Mulliez; A Gulyban; E Bogaert; T Vercauteren; T Van Hoof; J Van de Velde; R Van Den Broecke; C De Wagter; W De Neve Journal: Strahlenther Onkol Date: 2013-10-03 Impact factor: 3.621